このエントリーをはてなブックマークに追加
ID 65726
フルテキストURL
fulltext.pdf 2.48 MB
著者
Oguni, Kohei Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fukushima, Shinnosuke Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Yamamoto, Yukichika Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hasegawa, Kou Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hagiya, Hideharu Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID researchmap
Inoshita, Naoko Department of Pathology, Moriyama Memorial Hospital
Otsuka, Fumio Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
抄録
Octreotide is used in patients with insulinomas to treat hypoglycemia, and somatostatin receptor (SSTR) 2 expression is important for its efficacy. We report a case of insulinoma in a 50-year-old woman that responded to an octreotide test, showed accumulation in somatostatin scintigraphy, and was positive for SSTR2A on immunostaining.
キーワード
Insulinoma
octreotide test
somatostatin receptor
somatostatin scintigraphy
発行日
2023-08-02
出版物タイトル
Clinical Case Reports
11巻
8号
出版者
Wiley
開始ページ
e7771
ISSN
2050-0904
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2023 The Authors.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1002/ccr3.7771
ライセンス
https://creativecommons.org/licenses/by-nc-nd/4.0/
Citation
Oguni K, Fukushima S, Yamamoto Y, et al. Preoperative detection of functional somatostatin receptors in a patient with an insulinoma. Clin Case Rep. 2023;11:e7771. doi:10.1002/ccr3.7771